ACADIA PHARMACEUTICALS INC — Director's Dealing 2019

May 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2019-04-29

Reporting Person: KIM AUSTIN D. (EVP & General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-29	Stock Options (Right to Buy)	$25.12	A	42173	Acquired	2029-04-29	Common Stock (42173)	Direct
2019-04-29	Restricted Stock Units	$	A	12019	Acquired		Common Stock (12019)	Direct

Footnotes

F1: 25% of the shares subject to the Stock Option will vest and become exercisable on April 29, 2020. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

F2: Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.

F3: The restricted stock units vest in four equal annual installments beginning April 29, 2020.